Posts

NHS hospitals pay the price for staff exposure to chemicals

Exposure of hospital staff to chemicals is leading to a raft of claims for harm to their health.

According to NHS Resolution(1), they received 371 claims for harm caused by exposure to substances hazardous to health from incidents occurring between 1 April 2013 and 31 March 2023.

Of the 165 claims that were settled during that period, damages totalling £2,471,880 were paid out to claimants, with the NHS also having to pay out for defence costs.

At a time when money is tighter than ever in the NHS, avoiding costly claims is critical. But this is still only a secondary concern to the fact that staff are being wrongfully and dangerously exposed to hazardous substances in the workplace.

What sort of claims are being made?

Whilst the above claims relate to a variety of harmful substances including dust and hand hygiene products, it is interesting to note that a large percentage of claims come from chemicals and fumes.

For nurses (registered with the Nursing and Midwifery Council), 20% of claims arose from exposure to chemicals other than cleaning chemicals, whilst a further 25% came from dust and fumes.

For healthcare support staff the figures are more stark, with 40% of claims arising from exposure to chemicals other than cleaning chemicals, and 37.5% from dust and fumes.

Formalin, Acetic Acid and Peracetic Acid Exposure

Some of the chemicals used in hospitals that can pose a significant risk to healthcare staff are Formalin, Acetic Acid and Peracetic Acid (PAA).

In operating theatres, Formalin is used to preserve surgical tissue specimens for histological and pathological examination.

Formalin (formaldehyde) exposure can lead to eye, skin, nose, and throat irritation, and respiratory issues. A known human carcinogen, if staff are exposed to it over long periods of time in large amounts, they can develop bronchial asthma and possible organ damage.

In endoscopy, PAA is mainly used to sterilize or disinfect endoscopes and other reusable medical instruments after use. If exposed to PAA, staff can experience side effects such as breathing issues, eye or skin irritation, headaches, dizziness, and with higher exposures pulmonary oedema.

What action should hospitals take to protect staff?

The Control of Substances Hazardous to Health Regulations (COSHH) 2002 requires employers to carry out risk assessments on the use of hazardous substances.

This includes putting in place procedures and equipment to handle accidents such as Formalin and PAA spills. Staff must also be given adequate training into how to approach and clear spills safely to minimise the risk to their health.

By using a dedicated chemical spill station for chemicals such Formalin, Acetic Acid and Peracetic Acid, staff can clear spills safely and efficiently, using the correct personal protective equipment.

Some staff may need to use powered air fed respirator hoods where they have not been face-fit tested for the respirators in the chemical spill station or where they have facial hair that can interfere with the effectiveness of the respirator seal.

In addition, all staff should go through chemical spill management training to learn how to use the chemical spill station effectively and safely.

By assessing the risks of spills and providing the correct kit and training, NHS Trusts and private hospitals fulfil the important duty of care that they have for their staff. The result is not only likely to be fewer claims for personal injury, but more importantly far less harm to staff.

Can we help?

With 25 years of experience in handling chemical spills, and a range of spill kits developed in conjunction with healthcare staff, we can provide both the equipment and expertise to help you handle spills safely.

For information on chemical spill stations for Formalin, Acetic Acid and Peracetic Acid click here. Or for air-fed hood information click here.

For information on chemical spill management training click here.

Alternatively, call Cairn Technology’s chemical spill consultants on 0333 015 4345.

 

Keeping staff safe from inhalable and respirable dust

Dust monitoring in fracture clinicsIf you manage a fracture clinic plaster room or orthotics laboratory, it is important to ensure that your staff are protected against the risks of inhalable and respirable dust.

This was underlined again only this month in an HSE eBulletin, which revealed that the Health and Safety Executive had recently fined a stone worktop manufacturer £60,000 and a wood supplier £40,000 for failing to protect workers from harmful dust exposure.

Plaster of Paris dust generated in plaster rooms and orthotics laboratories can lead to short-term and long-term respiratory problems.

So, it is vital that employers provide proper ventilation systems, appropriate respiratory protection, and carry out regular health surveillance to protect their workers.

Inhalable and respirable dust monitoring

We carry out workplace exposure monitoring in fracture clinic plaster rooms and orthotics laboratories to measure staff exposure to total inhalable and respirable dust.

Levels of these dusts need to be measured in accordance with the methods outlined in the HSE Publications MDHS 14/3.

Monitoring for workplace exposure to respirable and inhalable dust.To ensure that this is done, we equip each member of staff with personal sampling pumps and monitor their exposure to dust during a normal working period.

We then provide you with a report which details the staff exposure levels and outlines whether there are any causes for concern.

We recommend that this inhalable and respirable dust monitoring procedure should be carried out every 12 months to ensure continued compliance with Regulation 10 of the Control of Substances Hazardous to Health (COSHH) regulations 2002 (as amended).

To discuss our inhalable and respirable dust monitoring service or get a quote, please call us on 0333 015 4345 or email info@cairntechnology.com

What about staff exposure to Diisocyanates?

We can also help measure your staff’s exposure for Diisocyanates through our Biological Sampling service.

Diisocyanates are now used more frequently in fracture clinics because of the move away from Plaster of Paris towards synthetic products. They are also being used more widely in prosthetic laboratories where the use of resins is becoming more commonplace.

They are highly reactive substances which are potent respiratory and skin sensitizers and a common cause of asthma and allergic contact dermatitis.

The increase in Diisocyanate usage, along with the British Orthopaedic Association’s adoption of worker training guidance from the EU, has highlighted the importance of monitoring staff exposure.​

We recommend that sampling should be carried out every 12 months to ensure continued compliance with Regulation 10 of the Control of Substances Hazardous to Health (COSHH) regulations 2002 (as amended).

If you are unsure whether or not your department is using products that contain Diisocyanates, our team can establish this on your behalf from the product material data sheets.

To discuss our Diisocyanate biological sampling service or get a quote, please call us on 0333 015 4345 or email us at info@cairntechnology.com